Literature DB >> 15027814

Substitution for natural musk in Pien Tze Huang does not affect its hepatoprotective activities.

W Y Chan1, F T Chau, K K H Lee, W H Kwong, D T Yew.   

Abstract

Previous studies showed that Pien Tze Huang, a Chinese folk medicine well known for its therapeutic activity in treating liver diseases, protected the liver against carbon tetrachloride (CCl4)-induced damage in mice. In the present study, natural musk, one of the important ingredients of Pien Tze Huang, was replaced by a formulated substitute, and the new formulation of Pien Tze Huang was shown to have similar chromatographic patterns to the original Pien Tze Huang in gas chromatography-mass spectrometry and high performance liquid chromatography. When used in treating mice with CCl4- or galactosamine-induced liver damage, both the original and new formulations of Pien Tze Huang were found to be able to suppress to a similar extent both the histopathological changes in the liver and the elevation of serum alanine aminotransferase and aspartate aminotransferase. Necrosis, cellular ballooning, microvesicular steatosis and lymphocytes infiltration were all significantly reduced in the damaged liver. In hepatoma cells, both formulations activated the activator protein 1 (AP1) enhancer sequence, indicating that both of them were able to act through the JNK signal transduction pathway. The results of the present study showed that the substitution for natural musk does not affect the hepatoprotective activities of Pien Tze Huang. It is also postulated that both formulations protect the liver through regulating signal transduction in the cell.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15027814     DOI: 10.1191/0960327104ht414oa

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  4 in total

Review 1.  Pien Tze Huang (PZH) as a Multifunction Medicinal Agent in Traditional Chinese Medicine (TCM): a review on cellular, molecular and physiological mechanisms.

Authors:  Zhiliang Chen
Journal:  Cancer Cell Int       Date:  2021-03-03       Impact factor: 5.722

2.  Traditional Chinese Medicine Pien-Tze-Huang Inhibits Colorectal Cancer Growth and Immune Evasion by Reducing β-catenin Transcriptional Activity and PD-L1 Expression.

Authors:  Qiang Chen; Yilin Hong; Shihe Weng; Peng Guo; Bei Li; Yong Zhang; Chundong Yu; Shicong Wang; Pingli Mo
Journal:  Front Pharmacol       Date:  2022-02-03       Impact factor: 5.810

3.  Pien-Tze-Huang alleviates CCl4-induced liver fibrosis through the inhibition of HSC autophagy and the TGF-β1/Smad2 pathway.

Authors:  Yuqin Zhang; Liping Hua; Chunfeng Lin; Mingzhou Yuan; Wei Xu; Anand Raj D; Baskar Venkidasamy; Carlos L Cespedes-Acuna; Shivraj Hariram Nile; Guohong Yan; Haiyin Zheng
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

Review 4.  Therapeutic Potential of Pien-Tze-Huang: A Review on Its Chemical Composition, Pharmacology, and Clinical Application.

Authors:  Lili Huang; Yiping Zhang; Xiaoqin Zhang; Xiuping Chen; Yitao Wang; Jinjian Lu; Mingqing Huang
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.